Trial Number
122-20
Conditions
Lung Cancer, Lung Nodules
Participant Age Range
18 years and older
Participant Gender
Any
Enrolling Participants
Yes
Overview
“I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients”
The objective of this study is to identify agents that will result in substantial improvement to the clinical condition of participants with ARDS.